Advances in Research of Arrhythmogenic Right Ventricular Cardiomyopathy

LIU Wen-ling

DOI: https://doi.org/10.3969/j.issn.1004-3934.2007.03.003

2007-01-01

Abstract:Arrhythmogenic right ventricular dysplasia/cardiomyopathy(ARVD/C) is a heart muscle disease characterized by peculiar right ventricular involvement and electrical instability that precipitates ventricular arrhythmias and sudden death.The latest advances in the diagnostic management of ARVC confirm that ARVC is not a rare disease(one affected in 1 000 to 1 250 inhabitants) and is of familial origin in 50% to 80% of cases,when it appears to follow an autosomal inheritance pattern.Diagnostic criteria defined in 1994 have contributed to low rates in the diagnosis of ARVC.Progress has been made in the definition of diagnostic markers.New criteria of localised right precordial QRS prolongation could be identified.The detection of epsilon potentials could be enhanced by highly amplified and modified recording techniques.After the characterisation of mutations in the plakophilin-2 gene,molecular genetics will become an important diagnostic tool.With the help of corrected and modified diagnostic criteria it seems to be possible to identify symptomatic and asymptomatic atrial fibrillation affected by ARVC with predominantly major criteria and,only in a minority of cases,minor criteria.Clinical research has indicated that successful treatment of ARVC is based on lifestyle modifications,prophylactic therapy(beta-blockers,amiodarone,sotalol,and ICD) to prevent sudden death.